Bertolotto A - Search Results

1

Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients.

Bertolotto A, Gilli F, Sala A, Capobianco M, Malucchi S, Milano E, Melis F, Marnetto F, Lindberg RL, Bottero R, Di Sapio A, Giordana MT. Bertolotto A, et al. Neurology. 2003 Feb 25;60(4):634-9. doi: 10.1212/01.wnl.0000046662.03894.c5. Neurology. 2003. PMID: 12601105 Clinical Trial.

2

Biochemical, histochemical and immunohistochemical study of glycosaminoglycans in human meningiomas.

Bertolotto A, Giordana MT, Orsi L, Orsi R, Schiffer D. Bertolotto A, et al. Basic Appl Histochem. 1989;33(3):239-49. Basic Appl Histochem. 1989. PMID: 2818425

3

Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients.

Bertolotto A, Capobianco M, Malucchi S, Manzardo E, Audano L, Bergui M, Bradac GB, Mutani R. Bertolotto A, et al. Neurosci Lett. 1999 Mar 19;263(1):21-4. doi: 10.1016/s0304-3940(99)00102-0. Neurosci Lett. 1999. PMID: 10218901

4

Quantitative PCR reveals increased levels of tumor necrosis factor-alpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses.

Bertolotto A, Malucchi S, Capobianco M, Manzardo E, Guastamacchia G, Milano E, Audano L, Mutani R. Bertolotto A, et al. J Interferon Cytokine Res. 1999 Jun;19(6):575-81. doi: 10.1089/107999099313703. J Interferon Cytokine Res. 1999. PMID: 10433357

5

Interferon beta neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations.

Bertolotto A, Malucchi S, Milano E, Castello A, Capobianco M, Mutani R. Bertolotto A, et al. Immunopharmacology. 2000 Jul 20;48(2):95-100. doi: 10.1016/s0162-3109(00)00182-x. Immunopharmacology. 2000. PMID: 10936507

6

Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification.

Bertolotto A, Gilli F, Sala A, Audano L, Castello A, Magliola U, Melis F, Giordana MT. Bertolotto A, et al. J Immunol Methods. 2001 Oct 1;256(1-2):141-52. doi: 10.1016/s0022-1759(01)00434-3. J Immunol Methods. 2001. PMID: 11516761

7

Evaluation of IFNalpha bioavailability by MxA mRNA in HCV patients.

Gilli F, Sala A, Bancone C, Salacone P, Gallo M, Gaia E, Bertolotto A. Gilli F, et al. Among authors: bertolotto a. J Immunol Methods. 2002 Apr 1;262(1-2):187-90. doi: 10.1016/s0022-1759(02)00008-x. J Immunol Methods. 2002. PMID: 11983232

8

Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory.

Bertolotto A, Malucchi S, Sala A, Orefice G, Carrieri PB, Capobianco M, Milano E, Melis F, Giordana MT. Bertolotto A, et al. J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):148-53. doi: 10.1136/jnnp.73.2.148. J Neurol Neurosurg Psychiatry. 2002. PMID: 12122172 Free PMC article.

9

Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse.

Milano E, Di Sapio A, Malucchi S, Capobianco M, Bottero R, Sala A, Gilli F, Bertolotto A. Milano E, et al. Among authors: bertolotto a. Neurol Sci. 2003 Oct;24(3):130-3. doi: 10.1007/s10072-003-0098-y. Neurol Sci. 2003. PMID: 14600824

10

Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.

Gilli F, Bertolotto A, Sala A, Hoffmann F, Capobianco M, Malucchi S, Glass T, Kappos L, Lindberg RL, Leppert D. Gilli F, et al. Among authors: bertolotto a. Brain. 2004 Feb;127(Pt 2):259-68. doi: 10.1093/brain/awh028. Epub 2003 Nov 7. Brain. 2004. PMID: 14607790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

376 results

Search Page

Filters